Head and neck cancer clinical trials

Explore recruiting head and neck cancer clinical trials.

Recruiting head and neck cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Head and neck cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PANACEA : Effect of PrehAbilitation by NutritionAl supplementation with Cannabidiol on skeletal muscle mass and mitochondrial function in hEad and neck cAncer : a proof of concept controlled randomized trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Fluorescence Intraoperative Surgical Margin Analysis in Head and Neck Cancer: Clinical Validation

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

DAHANCA 30 Et randomiseret non-inferiority studie af hypoxi-profilvejledt nimorazolbehandling i forbindelse med primær strålebehand-ling af planocellulære hoved-halskarcinomer

Norway, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Role of Hydroxychloroquine in therapeutic strategy of Head and Neck cancer and Non-small cell lung cancer

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase II trial evaluating treatment intensification with Ezabenlimab in patients with PD-L1–expressing, locally advanced head and neck squamous cell carcinoma (LA-HNSCC) with minimal residual disease (MRD) as detected by circulating tumor DNA (ctDNA) after curative-intent chemoradiation

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2a, double-blind, placebo-controlled, multi-center, randomized study evaluating LSTA1 when added to standard of care (SoC) versus standard of care alone in subjects with advanced solid tumors (BOLSTER)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Head and neck cancer trials by city

Head and neck cancer in Toronto Head and neck cancer in Vancouver Head and neck cancer in Montreal Head and neck cancer in Calgary Head and neck cancer in Edmonton Head and neck cancer in Ottawa Head and neck cancer in Winnipeg Head and neck cancer in Quebec City Head and neck cancer in Hamilton Head and neck cancer in Kitchener Head and neck cancer in London Head and neck cancer in Halifax Head and neck cancer in New York Head and neck cancer in Los Angeles Head and neck cancer in Chicago Head and neck cancer in Houston

Other conditions

Non-small cell lung cancer Colorectal cancer Pancreatic cancer Ovarian cancer Melanoma Leukemia Lymphoma Multiple myeloma Bladder cancer Kidney cancer Liver cancer Glioblastoma Cervical cancer Endometrial cancer Gastric cancer Age-related macular degeneration Diabetic retinopathy Glaucoma Dry eye disease HIV Hepatitis B Hepatitis C COVID-19 Influenza